14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CSII ranks #12532 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cardiovascular Systems Stock Forecast NASDAQ:CSII

$18.07 (0.44%)

Volume: 336k

Closed: Jan 21, 2022

Hollow Logo Score: -2.704

Cardiovascular Systems Stock Forecast

$18.07 (0.44%)

Volume: 336k

Closed: Jan 21, 2022

Score Hollow Logo -2.704

Cardiovascular Systems Company Profile

1225 Old Highway 8 Northwest

St. Paul MN 55112



Industry: Medical Devices

Sector: Healthcare

Cardiovascular Systems


Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. It offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Stealth 360° Peripheral OAS, Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, and Diamondback 360 2.00 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types, such as calcified plaque, in leg arteries both above and below the knee and address many of the limitations associated with other surgical, catheter, and pharmacological treatment alternatives, as well as Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE